LEADER 00900nam0-22002891i-450-
001 990000896960403321
005 20001010
035   $a000089696
035   $aFED01000089696
035   $a(Aleph)000089696FED01
035   $a000089696
100   $a20001010d--------km-y0itay50------ba
101 0 $aita
105   $ay-------001yy
200 1 $aPrimer Simposio National Sobre Materiales de Construccion 29, 30 Y 31 de Octubre 1987 Merida, Yucatan
210   $aMerida Yuc.$cUniversidad de Yucatan$d
215   $ap.487$cill.$dcm 28
610 0 $aSperimentazione
700  1$aRilem$0492296
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990000896960403321
952   $a03 SPER.0,30$bd.27$fIINTC
959   $aIINTC
996   $aPrimer Simposio National Sobre Materiales de Construccion 29, 30 Y 31 de Octubre 1987 Merida, Yucatan$9357107
997   $aUNINA
DB    $aING01

LEADER 02334oam  2200445Ia 450 
001 9910697575903321
005 20081024091028.0
035   $a(CKB)5470000002389191
035   $a(OCoLC)233049818
035   $a(EXLCZ)995470000002389191
100   $a20080702d2008      ua             0
101 0 $aeng
135   $auran|   uuuuu
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aTrends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 2005$b[electronic resource] /$fMarie N. Stagnitti
210  1$a[Rockville, Md.] :$cMedical Expenditure Panel Survey, Agency for Healthcare Research and Quality,$d[2008]
215   $a6 unnumbered pages $cdigital, PDF file
225 1 $aStatistical brief ;$v#205
300   $aTitle from title screen (viewed Sept. 12, 2008).
300   $a"May 2008."
320   $aIncludes bibliographical references.
330   $aThis Statistical Brief examines trends for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly know as statins, for the years 2000 and 2005. The data included in this brief are derived from 2000 and 2005 data for the U.S. civilian noninstitutionalized population from the Household Component of the Medical Expenditure Panel Survey (MEPS-HC). The brief compares 2000 and 2005 total expenditures, total number of purchases, and total number of persons purchasing, as well as average total expenditure and average number of purchases of statins for those with one or more statin purchases.
606   $aDrug utilization$xEconomic aspects$zUnited States
606   $aPrescription pricing$zUnited States
606   $aStatins (Cardiovascular agents)$zUnited States
615  0$aDrug utilization$xEconomic aspects
615  0$aPrescription pricing
615  0$aStatins (Cardiovascular agents)
700   $aStagnitti$b Marie N$01386624
712 02$aUnited States.$bAgency for Healthcare Research and Quality.
712 02$aMedical Expenditure Panel Survey (U.S.)
801  0$bVVK
801  1$bVVK
801  2$bGPO
906   $aBOOK
912   $a9910697575903321
996   $aTrends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 2005$93476447
997   $aUNINA